New chemo combo tested to stop colon Cancer's return
NCT ID NCT05179889
Summary
This study compares two different chemotherapy combinations given after surgery for high-risk stage III colon cancer. Researchers want to see which treatment better prevents the cancer from coming back. The trial will involve 308 patients who recently had successful colon cancer surgery. Participants will be randomly assigned to receive either the mFOLFIRINOX or mFOLFOX6 chemotherapy regimen.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER STAGE III are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chungnam National University Hospital
RECRUITINGDaejeon, 34112, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.